Open Orphan - Malaria Human Challenge Model Launched
ORPH Thu, 20 Jan 2022, 01:40pm GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
hVIVO, a subsidiary of Open Orphan has inoculated the first cohort of volunteers with a GMP-manufactured malaria challenge agent as part of its first controlled human malaria infection challenge study.